Skip to content
Open access · CC-BY via OpenAlex

Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis

Md Asiful Islam, Sayeda Sadia Alam, Shoumik Kundu, Saleh Ahmed, Shabiha Sultana, Azim Patar, Tareq Hossan

Journal of Clinical Medicine · 2023 · ▲ 38 citations

Abstract

The assurance of safety and effectiveness is a significant focal point in all therapeutic approaches. Although mesenchymal stem cells (MSCs) have been identified as a potential novel therapeutic strategy for multiple sclerosis (MS), existing evidence regarding the effectiveness and safety of this strategy remains inconclusive. Thus, the primary aim of this systematic review and meta-analysis (SRMA) was to comprehensively assess the effectiveness and safety of MSC therapy in individuals diagnosed with MS. A comprehensive search was conducted using appropriate keywords in the PubMed, Scopus, Cochrane, ScienceDirect, and Google Scholar databases to determine the eligible studies. The change in the expanded disability status scale (EDSS) score from baseline to follow-up was used to assess MSC efficacy. The effectiveness of the therapy was assessed using a random-effects model, which calculated the combined prevalence and 95% confidence intervals (CIs) for MS patients who experienced improvement, stability, or worsening of their condition. The protocol was registered in PROSPERO (CRD42020209671). The findings indicate that 40.4% (95% CI: 30.6-50.2) of MS patients exhibited improvements following MSC therapy, 32.8% (95% CI: 25.5-40.1) remained stable, and 18.1% (95% CI: 12.0-24.2) experienced a worsening of their condition. Although no major complications were observed, headaches 57.6 [37.9-77.3] and fever 53.1 [20.7-85.4] were commonly reported as minor adverse events. All of the results reported in this meta-analysis are consistent and credible according to the sensitivity analyses. Regardless of different individual studies, our meta-analysis provides a comprehensive overview showing the potential of MSC therapy as a possible effective treatment strategy for patients with MS.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/jcm12196311
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Islam, M.A., Alam, S.S., Kundu, S., Ahmed, S., Sultana, S., Patar, A., &amp; Hossan, T. (2023). Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis. <em>Journal of Clinical Medicine</em>. https://doi.org/10.3390/jcm12196311
Vancouver
Islam MA, Alam SS, Kundu S, Ahmed S, Sultana S, Patar A, et al. Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2023. doi:10.3390/jcm12196311.
BibTeX
@article{md2023Mesenc, title = {Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis}, author = {Md Asiful Islam and Sayeda Sadia Alam and Shoumik Kundu and Saleh Ahmed and Shabiha Sultana and Azim Patar and Tareq Hossan}, journal = {Journal of Clinical Medicine}, year = {2023}, doi = {10.3390/jcm12196311}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings